A detailed history of M&R Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, M&R Capital Management Inc holds 20,808 shares of ABT stock, worth $2.34 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
20,808
Previous 20,969 0.77%
Holding current value
$2.34 Million
Previous $2.38 Million 9.27%
% of portfolio
0.53%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$100.73 - $112.44 $16,217 - $18,102
-161 Reduced 0.77%
20,808 $2.16 Million
Q1 2024

Apr 02, 2024

SELL
$109.52 - $120.96 $22,670 - $25,038
-207 Reduced 0.98%
20,969 $2.38 Million
Q4 2023

Jan 02, 2024

SELL
$90.19 - $110.4 $137,269 - $168,028
-1,522 Reduced 6.71%
21,176 $2.33 Million
Q3 2023

Oct 10, 2023

SELL
$95.53 - $114.62 $159,152 - $190,956
-1,666 Reduced 6.84%
22,698 $2.2 Million
Q2 2023

Jul 05, 2023

SELL
$100.78 - $112.29 $2,116 - $2,358
-21 Reduced 0.09%
24,364 $2.66 Million
Q1 2023

Apr 03, 2023

SELL
$96.86 - $114.01 $85,139 - $100,214
-879 Reduced 3.48%
24,385 $2.47 Million
Q4 2022

Jan 11, 2023

SELL
$95.06 - $111.52 $28,422 - $33,344
-299 Reduced 1.17%
25,264 $0
Q3 2022

Oct 03, 2022

BUY
$96.76 - $112.03 $18,481 - $21,397
191 Added 0.75%
25,563 $2.47 Million
Q2 2022

Jul 05, 2022

BUY
$102.07 - $123.37 $29,906 - $36,147
293 Added 1.17%
25,372 $2.76 Million
Q1 2022

Apr 04, 2022

BUY
$114.02 - $139.04 $261,333 - $318,679
2,292 Added 10.06%
25,079 $2.97 Million
Q4 2021

Jan 07, 2022

BUY
$115.53 - $141.46 $111,024 - $135,943
961 Added 4.4%
22,787 $3.21 Million
Q3 2021

Oct 05, 2021

BUY
$116.66 - $129.06 $111,993 - $123,897
960 Added 4.6%
21,826 $2.58 Million
Q2 2021

Jul 02, 2021

SELL
$105.79 - $124.53 $43,902 - $51,679
-415 Reduced 1.95%
20,866 $2.42 Million
Q1 2021

Apr 01, 2021

SELL
$108.84 - $128.23 $204,075 - $240,431
-1,875 Reduced 8.1%
21,281 $2.55 Million
Q4 2020

Jan 05, 2021

SELL
$105.0 - $114.42 $41,370 - $45,081
-394 Reduced 1.67%
23,156 $2.54 Million
Q2 2020

Jul 01, 2020

SELL
$76.57 - $98.0 $106,585 - $136,416
-1,392 Reduced 5.58%
23,550 $2.15 Million
Q1 2020

Apr 02, 2020

BUY
$62.82 - $91.86 $3,141 - $4,593
50 Added 0.2%
24,942 $1.97 Million
Q4 2019

Jan 07, 2020

SELL
$78.51 - $87.4 $55,977 - $62,316
-713 Reduced 2.78%
24,892 $2.16 Million
Q3 2019

Oct 02, 2019

SELL
$81.84 - $88.74 $39,201 - $42,506
-479 Reduced 1.84%
25,605 $2.14 Million
Q2 2019

Jul 24, 2019

BUY
$72.88 - $85.0 $9,182 - $10,710
126 Added 0.49%
26,084 $2.19 Million
Q1 2019

Apr 29, 2019

BUY
$66.22 - $80.06 $66 - $80
1 Added 0.0%
25,958 $2.04 Million
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $24,978 - $28,296
381 Added 1.49%
25,957 $1.88 Million
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $3,709 - $4,474
61 Added 0.24%
25,576 $1.88 Million
Q2 2018

Aug 08, 2018

BUY
$57.57 - $63.54 $101,726 - $112,275
1,767 Added 7.44%
25,515 $1.56 Million
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $9,059 - $10,242
161 Added 0.68%
23,748 $1.42 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $36,126 - $38,677
-673 Reduced 2.77%
23,587 $1.35 Million
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $69,831 - $77,938
-1,453 Reduced 5.65%
24,260 $1.29 Million
Q2 2017

Aug 15, 2017

BUY
N/A
25,713
25,713 $1.25 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track M&R Capital Management Inc Portfolio

Follow M&R Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on M&R Capital Management Inc with notifications on news.